US HB478 | 2019-2020 | 116th Congress

Status

Spectrum: Moderate Partisan Bill (Democrat 13-3)
Status: Introduced on January 10 2019 - 25% progression, died in committee
Action: 2019-01-25 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]

Summary

Requires the Food and Drug Administration (FDA) to promulgate regulations within 180 days permitting individuals to import a prescription drug purchased from an approved Canadian pharmacy if the drug is dispensed by a pharmacist licensed in Canada; is purchased for personal use in quantities not greater than a 90-day supply; is filled using a valid prescription issued by a physician licensed to practice in the United States; and has the same active ingredients, route of administration, dosage form, and strength as a prescription drug approved by the FDA. Under the bill, certain drugs may not be imported, including controlled substances and biological products. The bill establishes a certification process for approving Canadian pharmacies. The FDA must publish a list of approved Canadian pharmacies.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Safe and Affordable Drugs from Canada Act of 2019

Sponsors


History

DateChamberAction
2019-01-25HouseReferred to the Subcommittee on Health.
2019-01-10HouseReferred to the House Committee on Energy and Commerce.
2019-01-10HouseIntroduced in House

Same As/Similar To

SB61 (Same As) 2019-01-09 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
SB3384 (Related) 2020-03-03 - Read twice and referred to the Committee on Finance.

Subjects


US Congress State Sources


Bill Comments

feedback